Breast Cancer research is a long and expensive process. It can take well over 15 years and $5 billion to translate a discovery in the lab into a new drug that can be used by patients. Breast cancer research is also time-consuming; it can take years to complete a single study. Although the investment in time and resources is significant, the potential impact is tremendous. Research is the only way we will discover and deliver the cures for breast cancer.
At Komen, we have a rigorous review process for selecting research grants, called peer-review. Peer-review is a grant review process used by many organizations, including the National Institutes of Health, to determine which research grants will be funded. By using this rigorous process, we strive to fund the very best research – funding projects that have the potential to advance the field and have an impact on patients as rapidly as possible.
Dr. Eric Winer, Chief Scientific Advisor
See how your
donations are fueling the best breast cancer research.
See how Komen researchers are making difference.
See what types of clinical trials Komen research has supported.
Learn how breast cancer survivors and advocates are involved in our scientific research.
Get more information on specific research funded
Learn about our Board of Directors, Scientific Advisory Board, Komen Scholars, Advocates in Science and more.
Discover the different ways you can help